Crippled by opioid-crisis litigation, Mallinckrodt settlement brings company closer to reorganisation
This has been a summer of reckoning for many companies that aggressively marketed opioids while downplaying their addictive power.
For Mallinckrodt, which filed for ...
Continue Reading →
